John Luddy

1.2k total citations
7 papers, 747 citations indexed

About

John Luddy is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, John Luddy has authored 7 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Physiology and 3 papers in Cancer Research. Recurrent topics in John Luddy's work include Cancer, Hypoxia, and Metabolism (3 papers), Alzheimer's disease research and treatments (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). John Luddy is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Alzheimer's disease research and treatments (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). John Luddy collaborates with scholars based in United States, China and Japan. John Luddy's co-authors include Shirley ShiDu Yan, David M. Stern, Lih‐Fen Lue, Anne‐Cécile Trillat, Jun Yao, Kazuhiro Takuma, Hongwei Xu, Xi Chen, Jianmin Huang and Ottavio Arancio and has published in prestigious journals such as Blood, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

John Luddy

7 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Luddy United States 5 392 371 174 135 103 7 747
Jiazhao Xie China 13 304 0.8× 220 0.6× 119 0.7× 111 0.8× 79 0.8× 20 610
Sören Mai Germany 10 464 1.2× 708 1.9× 74 0.4× 104 0.8× 84 0.8× 10 1.1k
Zhiyou Cai China 8 400 1.0× 215 0.6× 151 0.9× 102 0.8× 115 1.1× 10 671
N. Durany Spain 10 271 0.7× 245 0.7× 74 0.4× 92 0.7× 48 0.5× 12 581
Maria João Gama Portugal 18 167 0.4× 600 1.6× 128 0.7× 41 0.3× 52 0.5× 35 1.0k
Jingwei Xie China 11 249 0.6× 291 0.8× 117 0.7× 32 0.2× 104 1.0× 17 614
Sarah Mueller-Steiner United States 5 674 1.7× 393 1.1× 197 1.1× 29 0.2× 129 1.3× 6 1.2k
Gurdeep Marwarha United States 18 282 0.7× 408 1.1× 75 0.4× 26 0.2× 79 0.8× 34 967
Louise Théroux Canada 13 477 1.2× 302 0.8× 128 0.7× 47 0.3× 110 1.1× 18 851
Kathrin Schulz Germany 14 612 1.6× 635 1.7× 140 0.8× 50 0.4× 159 1.5× 15 1.1k

Countries citing papers authored by John Luddy

Since Specialization
Citations

This map shows the geographic impact of John Luddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Luddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Luddy more than expected).

Fields of papers citing papers by John Luddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Luddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Luddy. The network helps show where John Luddy may publish in the future.

Co-authorship network of co-authors of John Luddy

This figure shows the co-authorship network connecting the top 25 collaborators of John Luddy. A scholar is included among the top collaborators of John Luddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Luddy. John Luddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Pardee, Timothy S., King Lee, John Luddy, et al.. (2014). A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies. Clinical Cancer Research. 20(20). 5255–5264. 91 indexed citations
2.
3.
4.
Fang, Fang, Xiaochun Chen, Tianwen Huang, et al.. (2011). Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(2). 286–292. 132 indexed citations
5.
Fang, Fang, Lih‐Fen Lue, Shiqiang Yan, et al.. (2009). RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. The FASEB Journal. 24(4). 1043–1055. 274 indexed citations
6.
Takuma, Kazuhiro, Jun Yao, Jianmin Huang, et al.. (2005). ABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction. The FASEB Journal. 19(6). 1–25. 227 indexed citations
7.
Luddy, John, et al.. (1999). Ammonium-chloride-induced prostatic hypertrophy in vitro: urinary ammonia as a potential risk factor for benign prostatic hyperplasia. Urological Research. 27(5). 376–381. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiazhao Xie Breakdown of academic impact, for papers by Sören Mai Breakdown of academic impact, for papers by Zhiyou Cai Breakdown of academic impact, for papers by N. Durany Breakdown of academic impact, for papers by Maria João Gama Breakdown of academic impact, for papers by Jingwei Xie Breakdown of academic impact, for papers by Sarah Mueller-Steiner Breakdown of academic impact, for papers by Gurdeep Marwarha Breakdown of academic impact, for papers by Louise Théroux Breakdown of academic impact, for papers by Kathrin Schulz
Rankless by CCL
2026